HFE hemochromatosis: an overview about therapeutic recommendations
Hematol., Transfus. Cell Ther. (Impr.)
;
44(1): 95-99, Jan.-Mar. 2022. tab
Artículo
en Inglés
| LILACS
| ID: biblio-1364881
ABSTRACT
Abstract Hemochromatosis is currently characterized by the iron overload caused by hepcidin deficiency. Large advances in the knowledge on the hemochromatosis pathophysiology have occurred due to a better understanding of the protein of the iron metabolism, the genetic basis of hemochromatosis and of other iron overload diseases or conditions which can lead to this phenotype. In the present review, the main aims are to show updates on hemochromatosis and to report a practical set of therapeutic recommendations for the human factors engineering protein (HFE) hemochromatosis for the p.Cys282Tyr (C282Y/C282Y) homozygous genotype, elaborated by the Haemochromatosis International Taskforce.
Texto completo:
Disponible
Índice:
LILACS (Américas)
Asunto principal:
Trastornos del Metabolismo del Hierro
/
Hemocromatosis
Tipo de estudio:
Guía de Práctica Clínica
Límite:
Femenino
/
Humanos
/
Masculino
Idioma:
Inglés
Revista:
Hematol., Transfus. Cell Ther. (Impr.)
Asunto de la revista:
Hematologia
/
TransfusÆo de Sangue
Año:
2022
Tipo del documento:
Artículo
País de afiliación:
Brasil
Institución/País de afiliación:
Santa Casa de São Paulo/BR
/
Universidade Federal de São Paulo - UNIFESP/BR
Similares
MEDLINE
...
LILACS
LIS